OmniAb, Inc. (NASDAQ:OABI) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Sarah Boyce Other companies: Atrium Therapeutics, Inc. (Chair · Since at least Feb 26, 2026); Contineum Therapeutics, Inc. (Director · Since at least Jun 24, 2024); Avidity Biosciences, Inc (President and CEO, Director · Since at least Jun 11, 2020); Berkeley Lights Inc (Director · Jul 16, 2020 – May 14, 2021 · Past); Ligand Pharmaceuticals Incorporated (Director · Oct 15, 2019 – Jun 10, 2022 · Past); Akcea Therapeutics Inc (President, Director · Apr 17, 2018 – Jul 15, 2019 · Past); Ionis Pharmaceuticals, Inc. (Chief Business Officer · Jan 1, 2015 – Jan 15, 2018 · Past) | Director · Nov 1, 2022 – Jun 18, 2024 · Past |
| David F Burgstahler Other companies: Organogenesis Holdings Inc. (Director · Aug 17, 2018 – May 14, 2021 · Past); WideOpenWest Inc (Director · May 24, 2017 – Aug 6, 2019 · Past); Lantheus Holdings, Inc. (Director · Nov 21, 2016 – Sep 7, 2017 · Past); Syneos Health Inc (Director · Aug 24, 2016 – May 23, 2017 · Past); AngioDynamics, Inc. (Director · Jul 22, 2015 – Apr 12, 2017 · Past) | Director · Aug 9, 2021 – Jun 18, 2024 · Past |
| Kurt Gustafson Other companies: Xencor, Inc. (Director · Since at least Jul 14, 2014); Niagen Bioscience, Inc. (Director · Oct 21, 2016 – Jun 17, 2021 · Past); Spectrum Pharmaceuticals Inc (EVP & Chief Financial Officer · Jun 3, 2013 – Mar 15, 2022 · Past); Halozyme Therapeutics, Inc. (Vice President and CFO · Apr 13, 2009 – Feb 4, 2013 · Past) | Chief Financial Officer · Since at least Nov 1, 2022 |
| John Higgins Other companies: Immunome, Inc. (Chief Scientific Officer · Since at least Oct 2, 2023); Bio-Techne Corp (Director · Since at least Jun 4, 2019); Ligand Pharmaceuticals Incorporated (Director · May 14, 2019 – Dec 28, 2022 · Past) | Board Chair · Since at least Nov 1, 2022 |
| Matthew W. Foehr Other companies: Viking Therapeutics, Inc. (Director · Since at least Apr 13, 2016); AIxCrypto Holdings, Inc. (Director · Nov 29, 2016 – Jan 21, 2020 · Past); Ligand Pharmaceuticals Incorporated (President and COO · Aug 5, 2016 – Jun 10, 2022 · Past) | President and Chief Executive Officer · Since at least Nov 1, 2022 |
| Sriram Venkataraman Other companies: OptiNose (Director · Oct 12, 2017 – Jun 10, 2020 · Past); Lantheus Holdings, Inc. (Director · Jun 24, 2015 – Mar 17, 2017 · Past); AngioDynamics, Inc. (Director · May 22, 2012 – Aug 5, 2016 · Past) | Executive Vice President · Aug 9, 2021 – Aug 9, 2021 · Past |
| Thompson Dean Other companies: Hi-Crush Partners LP (Director · Aug 23, 2018 – Aug 23, 2018 · Past); Organogenesis Holdings Inc. (Director · Aug 17, 2018 – May 14, 2021 · Past); VWR Corp (Director · Oct 1, 2014 – Oct 7, 2014 · Past) | Director · Aug 9, 2021 – Jun 18, 2024 · Past |
| William E Klitgaard Other companies: Zapata Quantum, Inc. (Director · Since at least Mar 28, 2024); Syneos Health Inc (Director · Mar 1, 2017 – Sep 28, 2023 · Past); Covance Inc (Corporate Sr. Vice President · Feb 23, 2006 – Feb 19, 2015 · Past) | Director · Aug 9, 2021 – Aug 9, 2021 · Past |
| Carolyn R. Bertozzi Other companies: Eli Lilly and Company (Director · Since at least Nov 16, 2020); Alnylam Pharmaceuticals, Inc. (Director · Jan 5, 2023 – May 8, 2025 · Past) | Director · Since at least Nov 1, 2022 |
| Charles C Harwood Jr Other companies: Organogenesis Holdings Inc. (Director · Oct 7, 2016 – Dec 10, 2018 · Past); Syneos Health Inc (Director · Nov 6, 2014 – Aug 24, 2016 · Past) | Director · Aug 24, 2022 – Aug 24, 2022 · Past |
| Lale White Other companies: Cardiff Oncology, Inc. (Director · Since at least Apr 16, 2020); CombiMatrix Corp (Director · Mar 12, 2015 – Nov 14, 2017 · Past) | Director · Aug 9, 2021 – Aug 9, 2021 · Past |
| Sunil Patel Other companies: OncoMed Pharmaceuticals Inc (See Remarks · Jul 17, 2013 – Jan 4, 2018 · Past); Ligand Pharmaceuticals Incorporated (Director · Oct 7, 2010 – Jun 10, 2022 · Past) | Director · Nov 1, 2022 – Jun 23, 2023 · Past |
| Benjamin Silbert Other companies: Organogenesis Holdings Inc. (General Counsel and Secretary · Oct 7, 2016 – Oct 7, 2016 · Past) | General Counsel · Aug 9, 2021 – Aug 9, 2021 · Past |
| Charles Berkman Other companies: Ligand Pharmaceuticals Incorporated (SVP, Gen. Counsel & Secretary · Mar 1, 2007 – Jun 10, 2022 · Past) | Chief Legal Officer · Since at least Nov 1, 2022 |
| Jennifer Cochran Other companies: Ligand Pharmaceuticals Incorporated (Director · Jul 12, 2021 – Jun 10, 2022 · Past) | Board Member · Since at least Nov 1, 2022 |
| John Cafasso Other companies: Organogenesis Holdings Inc. (Chief Financial Officer · Oct 7, 2016 – Oct 7, 2016 · Past) | Chief Financial Officer · Aug 9, 2021 – Aug 9, 2021 · Past |
| Philip J Gotwals Other companies: Capricor Therapeutics, Inc. (Director · Since at least Jul 21, 2023) | Director · Since at least Apr 21, 2025 |
| Philip J. Gotwals Other companies: Capricor Therapeutics, Inc. (Director · Since at least Nov 4, 2026) | Board Member · Since at least May 8, 2025 |
| Steven C Crouse Other companies: Bio-Techne Corp (President - Diag & Spatial Bi · Since at least Mar 1, 2026) | Director · Since at least Apr 21, 2025 |
| Steven Love Other companies: Affymax Inc (Vice President, Finance · Aug 20, 2007 – May 4, 2010 · Past) | Director · Since at least Nov 1, 2023 |
| Amanda N Heravi | Investor Relations Officer · Aug 9, 2021 – Aug 9, 2021 · Past |
| Amechi Nwachuku | Chief Operating Officer · Since at least Jul 13, 2026 |
| Bill Harriman | Sr. Vice President, Discovery Partnership Management, Technology Development and Operations · Since at least Nov 4, 2026 |
| Bob Chen | Sr. Vice President, Discovery Systems · Since at least May 13, 2025 |
| Chris Silvia | Vice President, Data Sciences and Corporate IT · Since at least Nov 4, 2026 |
| Christel Iffland | Sr. Vice President, R&D Portfolio Management and Technology Operations · Since at least Nov 5, 2026 |
| Cia McCaffrey | Sr. Vice President, People and Talent · Since at least Nov 5, 2026 |
| Ellen Smith | Associate General Counsel, Intellectual Property and Licensing · Since at least Nov 5, 2026 |
| Joshua Alexander Tamaroff | Director · Nov 1, 2022 – Jun 18, 2024 · Past |
| Neil Castle | Vice President, Biology · Since at least Nov 5, 2026 |
| Robert Girardi | Executive Vice President · Aug 9, 2021 – Aug 9, 2021 · Past |
| Todd Pettingill | Vice President, Business Development and Strategy · Since at least Aug 17, 2026 |
| Yasmina Abdiche | Sr. Vice President, Exploratory Research · Since at least Dec 15, 2025 |